Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs

Abstract

These results suggest that YM155 sensitises tumour cells to platinum compounds both in vitro and in vivo, and that this effect is likely attributable to the inhibition of DNA repair and consequent enhancement of apoptosis.